RNA interference for the identification of disease-associated genes
- PMID: 15195924
RNA interference for the identification of disease-associated genes
Erratum in
- Curr Opin Mol Ther. 2005 Jun;7(3):282
Abstract
RNA interference (RNAi) has emerged as a novel cellular mechanism regulating gene expression at the post-transcriptional level and as a powerful tool to control gene function experimentally. Recent advances in the biology and application of RNAi include the definition of improved criteria for selecting effective small interfering RNA (siRNA) sequences, and the generation of vectors for the delivery of siRNAs and stable silencing of genes in mammalian cells, tissues and animals. High-throughput screening projects based on RNAi have been initiated to search for genes involved in basic biological processes and in complex pathological conditions such as cancer, autoimmunity and degenerative disorders. This research is helping to identify novel therapeutic targets for a range of diseases and may translate into novel clinical applications for RNAi.
Comment in
-
Findings of scientific misconduct.NIH Guide Grants Contracts. 2009 Jan 30:NOT-OD-09-040. NIH Guide Grants Contracts. 2009. PMID: 19186376 Free PMC article. No abstract available.
Similar articles
-
RNA interference (RNAi) in hematology.Ann Hematol. 2004 Jan;83(1):1-8. doi: 10.1007/s00277-003-0759-1. Epub 2003 Oct 22. Ann Hematol. 2004. PMID: 14574462 Review.
-
RNA interference as a novel and powerful tool in immunopharmacological research.Int Immunopharmacol. 2007 Apr;7(4):417-26. doi: 10.1016/j.intimp.2006.12.011. Epub 2007 Jan 22. Int Immunopharmacol. 2007. PMID: 17321464 Review.
-
Short interfering RNA (siRNA): tool or therapeutic?Clin Sci (Lond). 2006 Jan;110(1):47-58. doi: 10.1042/CS20050162. Clin Sci (Lond). 2006. PMID: 16336204 Review.
-
Control of HIV-1 replication by RNA interference.Virus Res. 2004 Jun 1;102(1):53-8. doi: 10.1016/j.virusres.2004.01.015. Virus Res. 2004. PMID: 15068880 Review.
-
Advances in cell-type specific delivery of RNAi-based therapeutics.IDrugs. 2010 May;13(5):325-31. IDrugs. 2010. PMID: 20432190 Review.
Cited by
-
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.Mol Cancer. 2010 Aug 18;9:218. doi: 10.1186/1476-4598-9-218. Mol Cancer. 2010. PMID: 20718987 Free PMC article.
-
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.J Transl Med. 2009 Jun 11;7:43. doi: 10.1186/1479-5876-7-43. J Transl Med. 2009. PMID: 19519883 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources